Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04315701 |
| Title | A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University of Southern California |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Los Angeles County-USC Medical Center | RECRUITING | Los Angeles | California | 90033 | United States | Details |
| USC / Norris Comprehensive Cancer Center | RECRUITING | Los Angeles | California | 90033 | United States | Details |
| Hoag Memorial Hospital | RECRUITING | Newport Beach | California | 92663 | United States | Details |
| Northwestern University Feinberg School of Medicine | RECRUITING | Chicago | Illinois | 60611 | United States | Details |
| University of Nebraska | RECRUITING | Omaha | Nebraska | 68198 | United States | Details |